These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29884619)

  • 1. CAABL-AF (California Study of Ablation for Atrial Fibrillation): Mortality and Stroke, 2005 to 2013.
    Srivatsa UN; Danielsen B; Amsterdam EA; Pezeshkian N; Yang Y; Nordsieck E; Fan D; Chiamvimonvat N; White RH
    Circ Arrhythm Electrophysiol; 2018 Jun; 11(6):e005739. PubMed ID: 29884619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of radiofrequency catheter ablation for atrial fibrillation on morbidity and mortality: a nationwide cohort study and propensity score analysis.
    Chang CH; Lin JW; Chiu FC; Caffrey JL; Wu LC; Lai MS
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):76-82. PubMed ID: 24446025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk predictors of stroke and mortality after ablation for atrial fibrillation: the California experience 2005-2009.
    Srivatsa UN; Danielsen B; Anderson I; Amsterdam E; Pezeshkian N; Yang Y; White RH
    Heart Rhythm; 2014 Nov; 11(11):1898-903. PubMed ID: 25048442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke.
    Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Jacobs V; Mallender C; Osborn JS; Weiss JP
    J Cardiovasc Electrophysiol; 2018 Feb; 29(2):221-226. PubMed ID: 29131434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction.
    Bunch TJ; May HT; Bair TL; Jacobs V; Crandall BG; Cutler M; Weiss JP; Mallender C; Osborn JS; Anderson JL; Day JD
    J Cardiovasc Electrophysiol; 2015 Apr; 26(4):363-370. PubMed ID: 25534572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter Ablation Improves Mortality and Other Outcomes in Real-World Patients With Atrial Fibrillation.
    Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B
    J Am Heart Assoc; 2020 Jun; 9(11):e015740. PubMed ID: 32427022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: A meta-analysis.
    Saglietto A; De Ponti R; Di Biase L; Matta M; Gaita F; Romero J; De Ferrari GM; Anselmino M
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1040-1047. PubMed ID: 32115777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the Cox-maze procedure for atrial fibrillation concomitant to mitral and tricuspid valve surgery.
    Ad N; Holmes SD; Massimiano PS; Pritchard G; Stone LE; Henry L
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1426-34; discussion 1434-5. PubMed ID: 24075462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic Differences in Catheter Ablation After Hospital Presentation With Symptomatic Atrial Fibrillation.
    Kummer BR; Bhave PD; Merkler AE; Gialdini G; Okin PM; Kamel H
    J Am Heart Assoc; 2015 Sep; 4(9):e002097. PubMed ID: 26396201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical ablation of atrial fibrillation trends and outcomes in North America.
    Ad N; Suri RM; Gammie JS; Sheng S; O'Brien SM; Henry L
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1051-60. PubMed ID: 22920597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal trends of in-hospital complications associated with catheter ablation of atrial fibrillation in the United States: An update from Nationwide Inpatient Sample database (2011-2014).
    Tripathi B; Arora S; Kumar V; Abdelrahman M; Lahewala S; Dave M; Shah M; Tan B; Savani S; Badheka A; Gopalan R; Shantha GPS; Viles-Gonzalez J; Deshmukh A
    J Cardiovasc Electrophysiol; 2018 May; 29(5):715-724. PubMed ID: 29478273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation.
    Noseworthy PA; Yao X; Deshmukh AJ; Van Houten H; Sangaralingham LR; Siontis KC; Piccini JP; Asirvatham SJ; Friedman PA; Packer DL; Gersh BJ; Shah ND
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26541393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Ullal AJ; Kaiser DW; Fan J; Schmitt SK; Than CT; Winkelmayer WC; Heidenreich PA; Piccini JP; Perez MV; Wang PJ; Turakhia MP
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):39-48. PubMed ID: 27782345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter ablation and mortality, stroke and heart failure readmission with atrial fibrillation.
    Pallisgaard JL; Lock Hansen M; Schjerning AM; Johannessen A; Gerds TA; Gustafsson F; Gislason GH; Torp-Pedersen C; Jacobsen PK; Kristensen SL; Koeber L; Munch A; Schou M
    Open Heart; 2020 Nov; 7(2):. PubMed ID: 33168641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000: report of a community-based study.
    Miyasaka Y; Barnes ME; Gersh BJ; Cha SS; Seward JB; Bailey KR; Iwasaka T; Tsang TS
    Stroke; 2005 Nov; 36(11):2362-6. PubMed ID: 16224079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Stroke and Recurrence After AF Ablation in Patients With an Initial Event-Free Period of 12 Months.
    Kochhäuser S; Alipour P; Haig-Carter T; Trought K; Hache P; Khaykin Y; Wulffhart Z; Pantano A; Tsang B; Birnie D; Verma A
    J Cardiovasc Electrophysiol; 2017 Mar; 28(3):273-279. PubMed ID: 27933666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation.
    Nademanee K; Amnueypol M; Lee F; Drew CM; Suwannasri W; Schwab MC; Veerakul G
    Heart Rhythm; 2015 Jan; 12(1):44-51. PubMed ID: 25257091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter Ablation.
    Bunch TJ; May HT; Bair TL; Jacobs V; Crandall BG; Cutler M; Weiss JP; Mallender C; Osborn JS; Anderson JL; Day JD
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):141-6. PubMed ID: 26443666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.